The role of invariant NKT cells at the interface of innate and adaptive immunity.
Cerundolo
Vincenzo
V
Kronenberg
Mitch
M
D056704:Adaptive Immunity; D000276:Adjuvants, Immunologic; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D055610:Antigens, CD1d / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D006017:Glycolipids / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007113:Immunity, Innate; D007167:Immunotherapy; D007239:Infections / Q000276:immunology* / Q000628:therapy; D055611:Natural Killer T-Cells / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D014612:Vaccines
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D055610:Antigens, CD1d; D001324:Autoantigens; D006017:Glycolipids; D014612:Vaccines